- fenamic acid
-
- $1.00 / 500g
-
2026-05-24
- CAS:91-40-7
- Min. Order: 300g
- Purity: 99.8%
- Supply Ability: 20 TONS
- Fenamic acid
-
- $78.00 / 500mg
-
2026-05-11
- CAS:91-40-7
- Min. Order:
- Purity: 99.61%
- Supply Ability: 10g
|
| | N-Phenylanthranilic acid Basic information |
| Product Name: | N-Phenylanthranilic acid | | Synonyms: | n-phenyl-anthranilicaci;N-Phenyl-o-anthranilicacid;o-anilinobenzoicacid;phenylanthranilicacid;Benzoic acid, 2-(phenylamino)-;N-Phenyl o-aminobenzoic acid;N-phenylanthranilieacid;N-PhenylanthranilicAcid99+% | | CAS: | 91-40-7 | | MF: | C13H11NO2 | | MW: | 213.23 | | EINECS: | 202-066-8 | | Product Categories: | | | Mol File: | 91-40-7.mol |  |
| | N-Phenylanthranilic acid Chemical Properties |
| Melting point | 182-185 °C (lit.) | | Boiling point | 353.22°C (rough estimate) | | bulk density | 200kg/m3 | | density | 1.1544 (rough estimate) | | refractive index | 1.5700 (estimate) | | storage temp. | Store below +30°C. | | solubility | DMSO: 125 mg/mL (586.22 mM) | | pka | pKa 5.28(5–10%aq. acetone t=25±0.1 I=0.11) (Uncertain) | | form | Fine Powder | | color | Light gray-green | | Water Solubility | insoluble | | Merck | 14,7273 | | BRN | 1456607 | | Major Application | peptide synthesis | | InChI | 1S/C13H11NO2/c15-13(16)11-8-4-5-9-12(11)14-10-6-2-1-3-7-10/h1-9,14H,(H,15,16) | | InChIKey | ZWJINEZUASEZBH-UHFFFAOYSA-N | | SMILES | OC(=O)c1ccccc1Nc2ccccc2 | | CAS DataBase Reference | 91-40-7(CAS DataBase Reference) | | EPA Substance Registry System | Phenylanthranilic acid (91-40-7) |
| Hazard Codes | Xi | | Risk Statements | 36/37/38 | | Safety Statements | 26-36-24/25 | | WGK Germany | 3 | | RTECS | CB3730000 | | TSCA | TSCA listed | | HazardClass | IRRITANT | | HS Code | 29224995 | | Storage Class | 11 - Combustible Solids | | Toxicity | LD50 ipr-mus: 235 mg/kg RPTOAN 37,105,74 |
| | N-Phenylanthranilic acid Usage And Synthesis |
| Chemical Properties | LIGHT GREY-GREEN TO YELLOW-GREEN FINE POWDER | | Uses | ion channel (Cl) blocker | | Uses | Detection of vanadium in steel. | | Uses | N-Phenylanthranilic acid is used in biological studies for inhibitors of aldo-keto reductase 1C3 based on N-phenyl-aminobenzoates. | | Definition | ChEBI: An aminobenzoic acid that is the N-phenyl derivative of anthranilic acid. It acts as a parent skeleton for the synthesis of several non-steroidal anti-inflammatory drugs. | | reaction suitability | reaction type: solution phase peptide synthesis | | Safety Profile | Poison by intravenous and intraperitoneal routes. When heated to decomposition it emits toxic fumes of NOx. | | Purification Methods | Crystallise the acid from EtOH (5mL/g) or AcOH (2mL/g) by adding hot water (1mL/g). [Beilstein 14 IV 1019.] |
| | N-Phenylanthranilic acid Preparation Products And Raw materials |
|